Book an Appointment
Emergency: 022-61305005
I want to find
My Health Records
Management Team

Alcoholic steatohepatitis (ASH)

Overview

Alcoholic steatohepatitis (ASH) is an advanced form of AFLD characterised by inflammation of the liver and fat accumulation in response to excessive alcohol consumption. It represents a progression from AFLD to more severe liver damage. If left untreated, it can lead to liver fibrosis, cirrhosis, and even liver failure.

The primary cause of ASH is excessive alcohol consumption. I have enumerated the causes and risk factors of ASH below.

  • Oxidative stress: Alcohol metabolism increases the production of reactive oxygen species (ROS), which contribute to oxidative stress and damage liver cells, leading to inflammation (hepatitis).
  • Toxic effects of alcohol: Acetaldehyde—a byproduct of alcohol metabolism—is toxic to liver cells and induces oxidative stress, leading to inflammation (hepatitis) and liver cell injury.
  • Fatty liver: AFLD coupled with inflammation can result in ASH.
  • Inflammation and immune response: Chronic alcohol consumption (prolonged and excessive consumption of alcohol) triggers an immune response, resulting in liver inflammation (hepatitis).

Several factors increase the risk of developing ASH, including:

  • Heavy and chronic alcohol consumption: Long-term alcohol abuse is the primary risk factor for ASH.
  • Malnutrition: Chronic alcohol use often leads to poor nutrition, which can enhance liver damage and increase the risk of developing ASH.
  • Genetics: Genetic predisposition plays a role in determining how individuals metabolise alcohol and how their liver responds to alcohol-induced damage. Specific genetic variations can make some individuals more prone to developing ASH.
  • Gender: Women are at higher risk of developing ASH than men due to differences in alcohol metabolism and liver function.
  • Age: With age, the liver becomes less efficient at metabolising alcohol, increasing the likelihood of liver damage.
  • Obesity and overweight: Individuals who are overweight or obese and are chronic alcohol consumers are at high risk of developing ASH.
  • Diabetes and insulin resistance: Type 2 diabetes and insulin resistance increase the risk of developing ASH, as high blood sugar levels and insulin resistance promote fat accumulation in the liver.
  • Other liver diseases: Individuals with a history of viral hepatitis (e.g., hepatitis C) or other pre-existing liver conditions are more likely to develop ASH if they consume alcohol.

In the early stages, ASH may not cause any noticeable symptoms. However, as the disease progresses, symptoms can become more apparent and include:

  • Fatigue: Affected individuals feel unusually tired or weak.
  • Abdominal pain or discomfort: Affected individuals feel discomfort, especially in the upper right part of the abdomen (where the liver is located).
  • Nausea (urge to vomit) and vomiting: These symptoms often accompany liver dysfunction.
  • Loss of appetite: Affected individuals feel a decreased desire to eat, leading to weight loss.
  • Enlarged liver (hepatomegaly): The liver becomes enlarged due to inflammation.

The first step in ASH diagnosis involves reviewing the complete medical history of the patient (alcohol consumption patterns, duration of drinking, and any history of liver disease or other related conditions). Other diagnostic strategies include:

  • Physical examination: A physical exam may reveal signs of liver enlargement, jaundice, or abdominal tenderness.
  • Blood tests:
    • Liver function tests: In ASH, the AST to ALT ratio tends to be higher (AST > ALT).
    • Complete blood count (CBC): This test can help detect abnormalities, such as low platelet counts, which are often seen in cirrhosis or advanced liver disease.
    • Bilirubin levels: Elevated bilirubin levels can indicate impaired liver function.
    • Albumin and prothrombin time: These tests assess the liver’s ability to produce clotting factors, a phenomenon that may be impaired in liver disease.
  • Imaging tests:
    • Ultrasound: This non-invasive technique can be used to check for liver enlargement and fat accumulation.
    • CT or MRI: These imaging modalities can provide more detailed images of the liver and may help identify fibrosis or cirrhosis.
    • Elastography: This specialised ultrasound technique is used to measure liver stiffness, which is an indicator of liver fibrosis or cirrhosis.
  • Liver biopsy: A liver biopsy may be performed to confirm the diagnosis of ASH, assess the degree of inflammation, and evaluate liver damage. It is often used when other tests do not provide definitive answers or if the disease progression needs to be assessed.

Stopping alcohol consumption is the most important step in treating ASH as continuing to drink alcohol can worsen liver inflammation and damage, leading to cirrhosis and liver failure. The treatment and management modalities of ASH include:

  • Support for alcohol cessation: Modalities, such as counselling, rehabilitation programs, or medications (e.g., disulfiram, naltrexone, or acamprosate) may be needed to help patients stop drinking.
  • Nutritional support: Individuals with ASH often suffer from malnutrition; therefore, proper dietary management is essential. A balanced diet rich in vitamins, minerals, and protein can help support liver regeneration. In some cases, nutritional supplements or enteral feeding may be necessary.
  • Medications: While there are no specific drugs approved for treating ASH, certain medications may be used to reduce liver inflammation and manage associated conditions:
    • Corticosteroids: In severe cases of ASH, corticosteroids (e.g., prednisolone) may be used to reduce inflammation, though their use is controversial and depends on the severity of the disease.
    • Antioxidants: Some studies suggest that vitamin E may help reduce liver inflammation, especially in non-diabetic patients.
  • Managing complications: Treating associated conditions, like diabetes, high cholesterol levels, or high blood pressure can help reduce the strain on the liver.
  • Regular monitoring: Individuals diagnosed with ASH require continuous monitoring to assess liver function, detect complications early, and adjust treatment as needed.

The best way to prevent ASH is to avoid heavy alcohol use. Other strategies include:

  • Maintaining a healthy weight: Obesity can enhance liver damage, so maintaining a healthy weight can help protect liver health.
  • Eating a balanced diet: A healthy diet supports liver function and reduces the risk of liver disease.
  • Avoiding excessive use of medications: Some drugs can accelerate liver damage, so it is important to avoid unnecessary medications or use them under the guidance of a healthcare provider.
Bottom to top